Tenvie Therapeutics News and Activities

Acquisition, funding and merger involving Tenvie Therapeutics.

• Tenvie Therapeutics has just announced a $200 Million fundraising (posted on January 31 2025).
• Tenvie Therapeutics has just announced a $200 Million fundraising (posted on January 30 2025).

View the org chart displaying its 21 main executives

Most searched biographies at Tenvie Therapeutics

• Tony Estrada, President and Chief Executive Officer
• Michele Cucullu, Director
• Paul Berns, Executive Chairman of the Board

Popular executive movements at Tenvie Therapeutics

• Don O'Sullivan has joined the company as Chief Business Officer  (posted on March 6 2026).

Create your alert
to follow the executive moves at Tenvie Therapeutics.

Tenvie Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Tenvie Therapeutics

Social media about Tenvie Therapeutics

• Tenvie Therapeutics on Wikipedia, Google News & Yahoo Finance
• Tenvie Therapeutics on LinkedIn, X (Twitter) & YouTube